The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: NUCRYST

Monday Biotech Deal Review: February 15, 2010

A busy Monday Deal Review is headlined by Labopharm and ProMetric on the securities front, MDS’ final divestiture on the M&Eh front and Biovail and Bioniche on the licensing front, and there’s lots more activity behind those for over $100 million of deals.  Check out all the details (and the witty headlines) after the jump…

Monday Biotech Deal Review: November 23, 2009

A slightly delayed Deal Review this week because of some non-biotech deal activity.  Live, from New York, it’s the Deal Review!

Read more of this post

Monday Biotech Deal Review: November 16, 2009

B&W_BigNickelThis week’s Canadian biotech roundup features a dose of all kinds of deals, though common shares appear to be figuring more prominently lately than they were earlier in 2009.  Lots of multijurisdictional activity too, with the U.S., the UK and Germany all participating in this week’s transactions. Other notable cross-border developments include the acquisition of IMS Health by CPP (and TPG), and Agrium’s continuing play for CF Industries.  Keep reading after the jump…

Follow

Get every new post delivered to your Inbox.

Join 129 other followers